The fourth quarter of 2022 saw a significant drop in Rabeprazole prices in North America, with CFR Los Angeles values falling by 5.8% from $108500/mt to $102150/mt from October to December. Due to a one-week holiday in China, a prominent exporter, imports of Rabeprazole were delayed the first week of October. Despite this, the US's downward pricing trend was sustained by the substantial stocks retained by domestic retailers and the low demand for Rabeprazole. The damaged supply chain did, however, begin to mend as the economy grew, and the port backlog significantly shrank in the second half of Q4.
During the fourth quarter of 2022, the price of Rabeprazole across the Asia Pacific region displayed a downward price trajectory. Between October and December, FOB Shanghai prices in China decreased from $88750/mt to $84250/mt. The first week of October saw a modest decline in Rabeprazole orders for China's API market due to the shutdown of production facilities for the Golden Week. After a one-week holiday and the market's reopening, domestic traders faced several conflicting signals that made it challenging for the players to keep up with the slow development seen in some downstream industries. Additionally, the weak demand for Rabeprazole kept the market moving downward. Government authorities altered their zero-covid restrictions in response to criticism and intense unhappiness in the nation, rendering it vulnerable in the second half of the fourth quarter of 2022.
The German market for Rabeprazole mimicked the same trend as that of North America and Asia. The CFR Hamburg prices were settled at $112000/mt and $108500/mt in October and December, respectively, demonstrating a downtrend. Offtakes were higher in the first half of the quarter than they were in December due to the unexpected increase in coronavirus infections, which led to a decline in international demand during the latter weeks of December. However, factors like COVID incidents and the conflict between Russia and Ukraine continued to have a negative impact on the economy as a whole. Germany's CPI also decreased at the conclusion of the year, along with the ease in supply chain issues.
ChemAnalyst tackles the primary difficulty areas of the worldwide chemical, petroleum, pharmaceutical, and petrochemical industries, empowering decision-makers to make informed decisions. It examines and analyses geopolitical risks, environmental concerns, raw material availability, supply chain functioning, and technological disruption. It focuses on market volatility and guarantees that clients manage obstacles and hazards effectively and efficiently. ChemAnalyst's primary expertise has been data timeliness and accuracy, benefiting both local and global industries by tuning in to real-time data points to execute multibillion-dollar projects internationally.